HomePRLD • NASDAQ
add
Prelude Therapeutics Inc
Previous close
$1.35
Day range
$1.30 - $1.40
Year range
$0.61 - $4.22
Market cap
86.43M USD
Avg Volume
2.58M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 6.50M | 116.67% |
Operating expense | 26.92M | -27.98% |
Net income | -19.72M | 38.88% |
Net profit margin | -303.46 | 71.79% |
Earnings per share | -0.26 | 39.53% |
EBITDA | -19.99M | 41.15% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 54.96M | -64.23% |
Total assets | 94.76M | -51.95% |
Total liabilities | 36.22M | -11.20% |
Total equity | 58.53M | — |
Shares outstanding | 82.40M | — |
Price to book | 1.75 | — |
Return on assets | -48.69% | — |
Return on capital | -60.00% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -19.72M | 38.88% |
Cash from operations | -19.12M | 29.97% |
Cash from investing | 40.09M | 273.53% |
Cash from financing | -5.00K | 96.18% |
Net change in cash | 20.97M | 225.62% |
Free cash flow | -12.36M | 23.72% |
About
Founded
2016
Headquarters
Website
Employees
131
